News
-
-
-
-
PRESS RELEASE
MedMira Announces Partnership with MediGroup Physician Services in the United States
MedMira Inc. partners with MediGroup, a key player in the US healthcare sector since 1999, to expand product reach to over 44,000 existing customers. The partnership allows MedMira to offer its rapid HIV test through MediGroup's network -
-
PRESS RELEASE
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
MedMira Inc. (TSXV:MIR) partners with Trimedic Inc. for exclusive distribution of Multiplo® TP/HIV and Reveal® G4 HIV-1/2 rapid antibody tests in Canada, aiming to improve access to rapid diagnostic testing solutions -
-
PRESS RELEASE
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
MedMira receives Investigational Testing Authorizations from Health Canada for clinical trials on new applications of its Multiplo® TP/HIV rapid test, expanding testing options in Canada amid rising syphilis and HIV cases -
-
PRESS RELEASE
MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
MedMira Inc. receives Health Canada approval for Reveal® Rapid G4 HIV-1/2 Test for POC use. Achieves 99.64% sensitivity & 99.71% specificity. Test offers immediate results for HIV detection